Abstract
Horvath’s epigenetic clock research has spotlighted a core set of 48 aging-related genes whose DNA methylation shifts closely track chronological age. These genes – including key transcription factors, splicing regulators, and developmental genes – play pivotal roles in regulating metabolism, maintaining epigenetic patterns, and preserving cellular identity. A unifying theme emerging from this work is the tight interplay between metabolic changes and epigenetic modifications during aging. For instance, older cells exhibit an imbalance in neurotransmitter metabolism: inhibitory GABA levels decline while excitatory glutamate accumulates, contributing to cellular stress and “dedifferentiation” of cell fate control. At the same time, levels of α-ketoglutarate (αKG) – a crucial TCA-cycle metabolite required for DNA demethylation – become depleted with age (due to waning metabolic flux and GABA depletion), impairing the αKG-dependent demethylation of DNA and leading to aberrant hypermethylation and silencing of protective “youth” genes. Compounding this metabolic-epigenetic shift, certain enzymes grow dysregulated with age: monoamine oxidase-B (MAO-B), a FAD-dependent enzyme, is upregulated in aging tissues and sequesters its FAD cofactor, while the NAD⁺-consuming enzyme CD38 is often overactivated, relentlessly hydrolyzing NAD⁺ The combined effect is a drain of two essential mitochondrial cofactors – NAD⁺ and FAD – which starves mitochondria of energy substrates and hampers key repair enzymes, thereby exacerbating cellular aging and dysfunction.Emerging evidence suggests that aging may be driven by such self-reinforcing metabolic and epigenetic disturbances, rather than by a one-way accumulation of random damage. In this view, a decline in metabolites like αKG and NAD⁺ triggers epigenetic dysregulation, which in turn further impairs metabolism, creating a vicious cycle or feedback loop that propels aging forward. This perspective also highlights promising therapeutic interventions aimed at breaking the loop. For instance, restoring αKG levels (through supplementation) could rejuvenate DNA demethylation activity and prevent the silencing of youthful genes, while boosting NAD⁺ (via precursors or CD38 inhibitors) helps sustain sirtuin enzymes and mitochondrial function. Likewise, inhibiting MAO-B could conserve FAD and mitigate oxidative byproducts, especially in the brain, thereby protecting mitochondrial efficiency. By targeting multiple nodes of this network, such interventions – alone or in combination – aim to restore metabolic and epigenetic homeostasis in aged cells Taken together, these findings paint a picture of aging as an actively regulated biological program orchestrated by intertwined metabolic, epigenetic, and mitochondrial dysfunctions.Rather than a passive wear-and-tear process, aging appears to be driven by a dynamic, maladaptive program – one that scientists may increasingly be able to modulate or even reset with multi-pronged therapies.
Continue Reading →